Low dose ara-c versus hydroxyurea with or without retinoid in older patients not considered fit for intensive chemotherapy: the UK NCRI AML 14 Trial

AK Burnett; Donald Milligan; AG Prentice; AH Goldstone; MF McMullin; Keith Wheatley

Low dose ara-c versus hydroxyurea with or without retinoid in older patients not considered fit for intensive chemotherapy: the UK NCRI AML 14 Trial

AK Burnett, Donald Milligan, AG Prentice, AH Goldstone, MF McMullin, Keith Wheatley

Research output: Contribution to journal › Abstract

Original language	English
Pages (from-to)	11
Number of pages	1
Journal	Blood
Volume	104
Publication status	Published - 1 Jan 2004

Cite this

@article{e9df8517be2249c3955eb1f14d51a4e1,

title = "Low dose ara-c versus hydroxyurea with or without retinoid in older patients not considered fit for intensive chemotherapy: the UK NCRI AML 14 Trial",

author = "AK Burnett and Donald Milligan and AG Prentice and AH Goldstone and MF McMullin and Keith Wheatley",

year = "2004",

month = jan,

day = "1",

language = "English",

volume = "104",

pages = "11",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Low dose ara-c versus hydroxyurea with or without retinoid in older patients not considered fit for intensive chemotherapy: the UK NCRI AML 14 Trial

AU - Burnett, AK

AU - Milligan, Donald

AU - Prentice, AG

AU - Goldstone, AH

AU - McMullin, MF

AU - Wheatley, Keith

PY - 2004/1/1

Y1 - 2004/1/1

M3 - Abstract

SN - 1528-0020

VL - 104

SP - 11

JO - Blood

JF - Blood

ER -